Lipid regulators market to reach $10.38 billion by 2030 at 5.9% CAGR, driven by increasing prevalence of cardiovascular diseases.
Read More
Microcarrier beads market to reach $4.95 billion by 2030 at 8.9% CAGR, driven by growing trend of personalized medicine.
Read More
Lifestyle-related disease supplements market to reach $91.73 billion by 2030 at 9.5% CAGR, driven by rising awareness of health and wellness.
Read More
Lichen nitidus treatment market to reach $2.91 billion by 2030 at 7.4% CAGR, driven by significant growth in chemical exposure and rising prevalence of skin infections.
Read More
Levofloxacin market to reach $2.42 billion by 2030 at 5.9% CAGR, driven by rising number of bacterial infections and increasing healthcare expenditure.
Read More
Leuprorelin drugs market to reach $3.95 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of prostate cancer and rising demand for ivf treatments.
Read More
Leuprolide acetate market to reach $3.71 billion by 2030 at 6.4% CAGR, driven by increasing prevalence of prostate cancer.
Read More
Leukotriene modifiers market to reach $30.63 billion by 2030 at 5.3% CAGR, driven by increasing incidence of asthma and allergic conditions.
Read More
Leukemia therapeutics market to reach $27.41 billion by 2030 at 8.0% CAGR, driven by rising prevalence of leukemia.
Read More
Leukemia inhibitory factor (lif) market to reach $1.37 billion by 2030 at 8.2% CAGR, driven by increasing number of clinical trials and rising healthcare expenditure.
Read More